Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground. But when he failed to get up and told us that his legs hurt, my husband and I grew ...
The FDA issued a safety communication that warns about possible Guillain-Barré syndrome (GBS) with respiratory syncytial virus (RSV) vaccines manufactured by Pfizer (Abrysvo) and GSK (Arexvy). The ...
Guillain-Barré syndrome (GBS) is a rare nerve disorder that can occur after an infection. It develops due to an overreaction of the immune system. There are several types of GBS. Guillain-Barré ...
The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased risk for Guillain-Barré Syndrome (GBS) within 42 days of vaccination based ...
SAN DIEGO -- A single dose of investigational tanruprubart resulted in rapid, sustained improvement in disability compared with placebo in patients with Guillain-Barré syndrome (GBS), a phase III, ...
Guillain-Barre syndrome (GBS) is an inflammatory disease that affects the nerves. It is thought to be an autoimmune disorder, and while the cause is not fully understood, it often arises after a ...
Annexon is a speculative Buy due to its late-stage Tanruprubart program targeting the high unmet need in Guillain-Barré Syndrome. Tanruprubart could become the standard of care for GBS if approved, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results